Alfasigma — Home

Potential partnering database (Report 00). Structured entry point.

Biotech event calendar and key milestones.

Outline companies meeting Alfasigma early-stage criteria with registry-backed facts and EUR-normalized funding.

Identify up to 20 partnering candidates, score PPI, and summarize funding, stage, and fit.

Analyze a company deck for fit to Alfasigma, covering snapshot, unmet need, modality, criteria scores, and recommendation.

Map all competitors and SoC by modality and company, with matrices and strategic fit.

Technical review of a new technology in an indication, covering disease need, modality rationale, competition, and strategy.

Identify leading KOLs with scoring, snapshots, visuals, and engagement recommendations.

Executive summary of funding and partnering trends for a modality/indication with implications and recent deals.

Full investor memo covering USP, science, plan, regulatory, CMC, IP, market, team, finances, and key questions.

Sell-side memo with market, epidemiology, pricing, rNPV model, comps, sensitivities, and appendix.

FTO analysis with patent tables, blocking claims, licensing, litigation, risk matrix, and mitigations.

CEO dossier on scientific record, leadership, exits, investors, company performance, and risks.

Shortlist and benchmark of 20+ CEO candidates with bios, scoring, and outreach plan.

Scout 20+ researchers for a scientific challenge with profiles, scorecard, and partnership guidance.

Excel landscape of pre-approval companies with selection criteria, universe table, shortlist, scoring matrix, and recommendations.